Docusign Envelope ID: 3C300328-0A03-4291-A61E-7AC76814510E 



**May Measurement Month (MMM) Trustees’ Annual Report for the period 19 November 2023 – 31 December 2024** 

**Charity Number: 1196683** 

**Version: V1** 

**May Measurement Month** 

7 Bell Yard, London, WC2A 2JR | Registered Charity No: 1196683 info@maymeasure.org | www.maymeasure.org 



Docusign Envelope ID: 3C300328-0A03-4291-A61E-7AC76814510E 


## **1. Introduction** 

## **1.1 Overview** 

This Trustees’ Annual Report outlines the activities, achievements and financial performance of May Measurement Month (MMM), a registered charity (Charity Number: 1196683) focused on raising awareness about the importance of measuring blood pressure (BP) and promoting early diagnosis and management of high BP (hypertension). 

## **1.2 Charity Objectives** 

The primary objectives of MMM are to: 

- Raise awareness of health issues surrounding high BP and emphasize the importance of regular blood pressure measurement 

- Encourage and facilitate opportunistic BP screenings in local communities 

- Collecting data from participating countries across the globe on BP levels and associated health issues to provide robust scientific data to assist governments with improving local BP screening facilities and associated health policies. 

- Support research and advocacy efforts to improve global hypertension management. 

## **1.3 Structure, Governance and Management** 

MMM is governed by a board of trustees who are responsible for the strategic direction and oversight of the charity. Trustees are appointed based on their expertise and commitment to the charity’s mission. Dayto-day operations are managed by a dedicated team of staff and volunteers. 

## **1.4 MMM Trustees and Management Team** 

## **MMM Board of Trustees** 

Professor Neil Reginald Poulter Professor Aletta Elisabeth Schutte Professor Markus Peter Schlaich 

Professor Georgios Stergiou Dr Thomas Beaney David Somen 

## **MMM Administration Team** 

Mrs Harsha McArdle Dr Gaia Kiru 

Campaign Manager Scientific Consultant 

## **May Measurement Month** 

7 Bell Yard, London, WC2A 2JR | Registered Charity No: 1196683 info@maymeasure.org | www.maymeasure.org 



Docusign Envelope ID: 3C300328-0A03-4291-A61E-7AC76814510E 


## **2. Achievements and Performance** 

## **2.1 Key Activities and Achievements** 

During the reporting period, MMM: 

- Conducted BP screening events in 63 countries (see Appendix 1), reaching 854,786 individuals. 

- Developed and distributed educational materials on hypertension prevention and management. 

- Partnered with global health organisations and clinics to provide training and resources for BP detection and management. 

## **2.2 Beneficiaries and Impact** 

Since its launch in 2017, MMM BP screening has been carried out in over 7 million people globally resulting in just over one million individuals being identified as having untreated or inadequately controlled hypertension. Countless others have been made aware of the impact of BP through MMM educational and awareness initiatives. Early detection and management of hypertension have been shown to significantly reduce the risk of cardiovascular disease and stroke. 

## **3. Financial Review** 

## **3.1 Income and Expenditure** 

MMM’s total income for the reporting period was £279,714, and total expenditure was £394,179. 

## **3.2 Reserves Policy** 

MMM maintains a reserves policy to ensure sufficient funds are available to cover operational costs and any unexpected expenses. At the end of the reporting period, MMM held reserves of £150,362. 

## **3.3 Financial Stability** 

MMM continues to diversify its income streams and seek funding opportunities to ensure long-term financial sustainability. 

## **4. Plans for the Future** 

## **4.1 Strategic Priorities** 

MMM’s strategic priorities for the next reporting period include: 

- Expanding BP screening events in new countries and communities. 

- Enhancing partnerships with global health organisations and organisations – including International Society of Hypertension (ISH), World Heart Federation (WHF), Resolve to Save Lives (RTSL), AFSCREEN, Servier, Omron, Medtronic and AstraZeneca. 

- Developing innovative educational and awareness campaigns in new areas of screening closely associated with high BP such as atrial fibrillation and air pollution. 

**May Measurement Month** 

7 Bell Yard, London, WC2A 2JR | Registered Charity No: 1196683 info@maymeasure.org | www.maymeasure.org 



Docusign Envelope ID: 3C300328-0A03-4291-A61E-7AC76814510E 


## **4.2 Key Initiatives** 

To achieve MMM’s strategic priorities in the coming year, the charity proposes to implement the following strategies and actions: 

- Expand BP screening and awareness in new countries and communities. 

- Enhance relationships with Global Health Organisations and Industry Partners. 

- Develop innovative educational and awareness campaigns in new research areas and provide educational materials and screening for areas closely associated with high BP including atrial fibrillation and other BP related conditions. 

By implementing these strategies and actions, MMM will work towards achieving its strategic priorities for the next reporting period, expanding its reach, and making a significant impact on global hypertension awareness and control. 

## **May Measurement Month** 

7 Bell Yard, London, WC2A 2JR | Registered Charity No: 1196683 info@maymeasure.org | www.maymeasure.org 



Docusign Envelope ID: 3C300328-0A03-4291-A61E-7AC76814510E 


## **5. Financial Reporting** 

## **5.1 Statement of Financial Activities for the Period Ended 31 December 2024** 

|**Note**<br>**Income**<br>Cash Donations<br>Donations of equipment<br>**Total Income**<br>**Expenditure**<br>Devices Donated<br>Devices, Printing & Distribution Expenses<br>Advertising & Marketing<br>Administrative and Management Fees<br>Research<br>Postage & Courier Costs<br>IT Software & Consumables<br>Legal Expenses<br>Charitable Donations Provided to a Number of LMIC<br>Countries to Support MMM Activities (see appendix 2)<br>Insurance<br>Bank Fees<br>Accountancy Fees<br>Rent<br>Irrecoverable VAT & Other Costs<br>Total Expenditure<br>**Net Expenditure before other recognised gains and**<br>**losses**<br>**Other recognised gains and losses**<br>Realised profit/(loss) on foreign currency transactions<br>Unrealised profit/(loss) on revaluation of cash reserves<br>**Net income for the year**<br>All the charities activities derive from continuing operations.|**2024**<br>**£**<br>171,234<br>108,480<br>**279,714**<br>(108,480)<br>(24,601)<br>(17,482)<br>(100,670)<br>(15,207)<br>(28,603)<br>(11,926)<br>(90)<br>(32,812)<br>(6,297)<br>(365)<br>(1,013)<br>-<br>(46,633)<br>(394,179)<br>**(114,465)**<br>25<br>(18,108)<br>**(132,548)**|**2023***<br>**£**<br>233,617<br>76,230|
|---|---|---|
|||**310,166**|
|||(76,230)<br>(1,679)<br>(14,886)<br>(102,188)<br>(48,507)<br>(14,366)<br>(7,130)<br>(120)<br>(1,775)<br>(6,472)<br>(441)<br>(972)<br>(1,538)<br>(553)|
|||(276,857)|
|||**33,309**|
|||108<br>(10,076)|
|||**23,341**|
||||



## **May Measurement Month** 

7 Bell Yard, London, WC2A 2JR | Registered Charity No: 1196683 info@maymeasure.org | www.maymeasure.org 



Docusign Envelope ID: 3C300328-0A03-4291-A61E-7AC76814510E 


_(* Please note the 2023 comparatives have been restated to take account of a change in accounting policy regarding the recognition of the value of devices donated to the charity and their distribution, and also a correction in the recognition of foreign currency balances)_ 

## **May Measurement Month** 

7 Bell Yard, London, WC2A 2JR | Registered Charity No: 1196683 info@maymeasure.org | www.maymeasure.org 



Docusign Envelope ID: 3C300328-0A03-4291-A61E-7AC76814510E 


## **5.2 Balance Sheet as at 31 December 2024** 

|**.2**<br>**Balance Sheet as at 31 December 2024**|||
|---|---|---|
|**Note**<br>**Current Assets**<br>Cash at bank and in hand<br>Accounts Receivable<br>Other Debtors<br>**Creditors: Amounts falling due within one**<br>**year**<br>2<br>**Net Current Assets**<br>**Net Assets**<br>**Funds of the charity:**<br>Unrestricted funds<br>**Total Funds**|**2024**<br>**£**<br>150,362<br>-<br>-<br>-<br>150,362<br>**150,362**<br>150,362<br>**150,362**|**2023***<br>**£**<br>250,956<br>-<br>34,743<br>(2,789)|
|||282,910|
|||**282,910**|
|||282,910|
|||**282,910**|



_(* Please note the 2023 comparatives have been restated to take account of a change in accounting policy regarding the recognition of the value of devices donated to the charity and their distribution, and also a correction in the recognition of foreign currency balances)_ 

The financial statements on pages 5 to 9 were approved by the trustees, and authorised for issue on 28 October 2025 and signed on their behalf by: 


Professor Neil Poulter 

Chair of Trustees, May Measurement Month 

**May Measurement Month** 

7 Bell Yard, London, WC2A 2JR | Registered Charity No: 1196683 info@maymeasure.org | www.maymeasure.org 



Docusign Envelope ID: 3C300328-0A03-4291-A61E-7AC76814510E 


## **5.3 Notes to the Financial Statements** _**for the Year Ended 31 December 2024**_ 

## **1 Accounting Polices** 

## **Statement of Compliance** 

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their  accounts in accordance with the Financial Reporting Standard applicable in the UKL and Republic of Ireland (FRS 102) (Effective 1 January 2015) – (Charities SOPR (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011. 

## **Basis of Preparation** 

May Measure Month meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes. 

## **Exemption from preparing a cash flow statement** 

The charity has turnover below £500,000 and therefore under Bulletin 1 published on 2 February 2016 it has not included a cash flow statement in these financial statements. 

## **Going Concern** 

The trustees consider that there are no material uncertainties about the charity’s ability to continue as a going concern nor any significant areas of uncertainty that affect the carrying value of assets held by the charity. 

## **Income** 

All income is recognised when the Charity is entitled to the income, there is sufficient certainty of receipt and so it is probable that the income will be received, and the amount can be reliably measured. 

Donations and grants are included in the statement of financial activities when receivable by the Charity. Income from grants is recognised at fair value when the charity has entitlement after any performance conditions have been met, it is probable that the income will be received and the amount can be measured reliably. If entitlement is not met then these amounts are deferred. 

## **Expenditure** 

Expenditure is recognised on an accruals basis as soon as there is a legal or constructive obligation committing the trust to the expenditure, it is probable that the settlement will be required and the amount of the obligation can be measured reliably. Expenditure includes any VAT which cannot be fully recovered, which is reported as part of the expenditure to which it relates. 

## **Investments** 

Fixed asset investments, other than programme related investments, are included at market value at the balance sheet date. Realised gains and losses on investments are calculated as the difference between sales proceeds and their market value at the start of the year, or their subsequent cost, and are charged or credited to the Statement of Financial Activities in the period of disposal. 

Unrealised gains and losses represent the movement in the market values during the year and are credited or charged to the Statement of Financial Activities based on the market value at the year end. 

## **Debtors and creditors** 

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in expenditure. 

## **May Measurement Month** 

7 Bell Yard, London, WC2A 2JR | Registered Charity No: 1196683 info@maymeasure.org | www.maymeasure.org 



Docusign Envelope ID: 3C300328-0A03-4291-A61E-7AC76814510E 


## **5.4 Notes to the Financial Statements** _**for the Year Ended 31 March 2023**_ 

## **Cash and cash equivalents** 

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value. 

## **Fund structure** 

Unrestricted income funds are general funds that are available for use at the trustee’s discretion in furtherance of the objectives of the charity. 

## **Staff** 

No staff are employed, and no remuneration or reimbursed expenses were paid to trustees during the year. 

## **Related Party Transactions** 

There were no related party transactions requiring disclosure in the year. 

## **2 Creditors: amounts falling due within one year** 

||**2024**|**2023**|
|---|---|---|
||**£**|**£**|
|Trade Creditors|-|(625)|
|Overdrafts|-|(2,164)|



**May Measurement Month** 

7 Bell Yard, London, WC2A 2JR | Registered Charity No: 1196683 info@maymeasure.org | www.maymeasure.org 



Docusign Envelope ID: 3C300328-0A03-4291-A61E-7AC76814510E 


## **6. Declaration** 

## **6.1 Trustee Approval** 

We, the undersigned Trustees, have approved this annual report on 28 October 2025 

**Professor Neil Reginald Poulter Professor Aletta Elisabeth Schutte Professor Markus Peter Schlaich Professor Georgios Stergiou Dr Thomas Beaney David Somen** 

**May Measurement Month** 

7 Bell Yard, London, WC2A 2JR | Registered Charity No: 1196683 info@maymeasure.org | www.maymeasure.org 



Docusign Envelope ID: 3C300328-0A03-4291-A61E-7AC76814510E 


## **Appendix 1** 

## **Countries that participated in MMM24** 

1. Albania 

2. Argentina 

3. Armenia 

4. Australia 

5. Bahrain 

6. Bangladesh 

7. Barbados 

8. Belgium 

9. Bulgaria 

10. Canada 

11. Chile 

12. China 

13. Colombia 

14. Congo, Democratic Republic 

15. Congo, Republic of 

16. Croatia 

17. Cyprus 

18. Egypt 

19. England 

20. France 

21. Georgia 

22. Ghana 

23. Greece 24. Hungary 25. India 

26. Ireland 

27. Israel 28. Italy 

29. Kazakhstan 30. Kenya 31. Libya 

   33. Malaysia 

   34. Mali 

   35. Mauritius 

   36. Mexico 

   37. Mongolia 38. Mozambique 

   39. Nepal 40. Nigeria 41. Oman 42. Paraguay 43. Philippines 44. Poland 45. Portugal 46. Romania 47. Scotland 48. Sierra Leone 49. Slovakia 

   50. Slovenia 51. South Africa 52. South Korea 53. Sri Lanka 54. Sudan 55. Switzerland 56. Thailand 57. Uganda 58. Ukraine 59. United Arb Emirates 

   60. Venezuela 

   61. Vietnam 

   62. Wales 

   63. Zambia 

32. Lithuania 

## **May Measurement Month** 

7 Bell Yard, London, WC2A 2JR | Registered Charity No: 1196683 info@maymeasure.org | www.maymeasure.org 



Docusign Envelope ID: 3C300328-0A03-4291-A61E-7AC76814510E 


## **Appendix 2** 

## **Countries who received donations from MMM charity to carry out MMM BP screening activity in their country** 

1. Burundi* 

2. Egypt 

3. Ghana 

4. India 

5. Malawi 

6. Rwanda* 

7. Sri Lanka 

8. Sudan 

9. Uganda 

_*Campaign donations were approved and received in both countries; however, due to internal constraints within each country, the allocated funds were deferred to the following campaign year._ 

## **May Measurement Month** 

7 Bell Yard, London, WC2A 2JR | Registered Charity No: 1196683 info@maymeasure.org | www.maymeasure.org 

